Brian Mullan, Ph.D., Head, Innovation, Analytical and Process Development
Corbeil-Essonnes, France
Yposkesi is a leading Contract Development and Manufacturing Organization (CDMO) for gene therapy vector manufacturing. Created in November 2016 in Corbeil-Essonnes, France by AFM-Telethon and the SPI fund managed by Bpifrance, Yposkesi provides integrated services covering bioprocess development (USP and DSP) from small/pilot to large-scale production, analytical development, GMP manufacturing of lentiviral and AAV vectors, and regulatory support. Our current facility consists of a 50,000f2 (approx. 5,000m2) building, operating multiple production suites for bulk drug substance manufacturing and fill and finish. By 2022, Yposkesi will increase its global footprint to 100,000ft2 (approx. 10,000m2) with the addition of a second large-scale facility designed for EMA and FDA compliance. Capitalizing on the more than 25 years of expertise of Genethon, Yposkesi invests significantly in innovation in bioprocessing to deliver on high quality projects, cost effectively. Yposkesi has also entered into several strategic partnerships with numerous biotech and pharmaceutical companies, at various stages of product development. www.yposkesi.com

By using this website you agree to accept our Privacy Policy and Terms & Conditions